EP3744325
APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.1.2019EP published:
7.6.2023EP application number:
19740851.1
EPO information:
European Patent Register
Max expiry date:
15.1.2039
Title in English:
APPLICATION OF NOVEL TYROSINE KINASE INHIBITOR, ANLOTINIB, IN OSTEOSARCOMA AND CHONDROSARCOMALanguage of the patent:
English
Timeline
Today
16.1.2019EP application
7.6.2023EP Publication
Owner
Name:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Address:
No. 369 Yuzhou South Road, Lianyungang, Jiangsu 222062, CN
Inventor
Name:
HUA, YingqiAddress:
Shanghai 200080, CN
Name:
WANG, GangyangAddress:
Shanghai 200080, CN
Name:
CAI, ZhengdongAddress:
Shanghai 200080, CN
Name:
WANG, ZhuoyingAddress:
Shanghai 200080, CN
Name:
ZHANG, TaoAddress:
Shanghai 200080, CN
Name:
WANG, HongshengAddress:
Shanghai 200080, CN
Name:
SUN, MengxiongAddress:
Shanghai 200080, CN
Name:
WANG, XunqiangAddress:
Lianyungang, Jiangsu 222062, CN
Name:
ZHAN, XiaoleAddress:
Lianyungang, Jiangsu 222062, CN
Name:
YANG, ZhaoqiangAddress:
Lianyungang, Jiangsu 222062, CN
Name:
TU, LifanAddress:
Lianyungang, Jiangsu 222062, CN
Name:
LI, PuAddress:
Lianyungang, Jiangsu 222062, CN
Priority
Number:
201810058487Date:
22.1.2018Country:
CN
Classification
Categories:
A61K 31/4709, A61P 35/00, A61K 33/243, A61P 35/04